✦ LIBER ✦

NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats

✍ Scribed by R.H. Wessell; S.M. Ahmed; F.S. Menniti; G.L. Dunbar; T.N. Chase; J.D. Oh

Book ID: 116784073
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 370 KB
Volume: 47
Category: Article
ISSN: 0028-3908
DOI: 10.1016/j.neuropharm.2004.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-NMDA receptor-mediated mechanisms ar

Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in parkinsonian rats

✍ Concepció Marin; Anna Jimenez; Mercè Bonastre; Thomas N. Chase; Eduardo Tolosa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

Chronic dopaminomimetic administration to parkinsonian animal models or Parkinson's disease patients leads to characteristic alteration in motor response. Previous studies suggested that the nonphysiologic stimulation of dopaminergic receptors on striatal medium spiny neurons enhances the synaptic e

CP-101,606, an NR2B subunit selective NM

CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents

✍ Frank S Menniti; Martin J Pagnozzi; Paul Butler; Bertrand L Chenard; Sarah S Jaw 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 844 KB

The NR2B-selective NMDA receptor antagon

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease

✍ J.E. Nash; P. Ravenscroft; S. McGuire; A.R. Crossman; F.S. Menniti; J.M. Brotchi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 728 KB